Probiotic Spore Formers Enhances Host Health

Keerthi Tr
{"title":"Probiotic Spore Formers Enhances Host Health","authors":"Keerthi Tr","doi":"10.19080/IJCSMB.2018.05.555651","DOIUrl":null,"url":null,"abstract":"The concept of probiotics has a long history of health claims. For example, in a Persian version of the Old Testament (Genesis 18:8), it states “Abraham owed his longevity to the consumption of sour milk. Replacing in-feed antibiotics with non-antibiotic alternatives is, therefore, an ever-increasing necessity. However, the withdrawal of all growth promoting factors is not a simple matter since this will not only affect feed efficiency but will also increase the mortality and morbidity of animals [1]. Sporeformers are capable of growth and metabolic activity only when in the vegetative state, and resort to sporulation when conditions of inadequate nutrition or other challenge to survival is experienced [2]. Currently, there is no universalclass of probiotic bacterium although the most common types available are lactic acid bacteria (e.g., Lactobacillus spp.). These bacteria are found normally in the gastrointestinal tract (GIT) of humans and animals and there is the vague notion that the use of indigenous or commensal microorganisms is somehow restoring the natural microflora to the gut. A second class comprises those that are not normally found in the GIT. For example, Saccharomyces boulardii has been shown to be effective in preventing the recurrence of Clostridium difficile-induced pseudo membranous colitis [3] as well as the antagonistic action of Escherichia coli [4]. S. boulardii products are currently being marketed for human use. Within this group of allochthonous probiotic microbes are the sporeforming bacteria, normally members of the genus Bacillus. Here, the product is used in the spore form and thus can be stored indefinitely on the shelf. The use of spore-based products raises a number of questions though. Since the bacterial species being used are not considered resident members of the gastrointestinal microflora how do they exert a beneficial effect? Because the natural life cycle of Initial efforts to document a physiological impact of probiotic bacteria often focus on the following three criteria:","PeriodicalId":93190,"journal":{"name":"International journal of cell science & molecular biology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of cell science & molecular biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19080/IJCSMB.2018.05.555651","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The concept of probiotics has a long history of health claims. For example, in a Persian version of the Old Testament (Genesis 18:8), it states “Abraham owed his longevity to the consumption of sour milk. Replacing in-feed antibiotics with non-antibiotic alternatives is, therefore, an ever-increasing necessity. However, the withdrawal of all growth promoting factors is not a simple matter since this will not only affect feed efficiency but will also increase the mortality and morbidity of animals [1]. Sporeformers are capable of growth and metabolic activity only when in the vegetative state, and resort to sporulation when conditions of inadequate nutrition or other challenge to survival is experienced [2]. Currently, there is no universalclass of probiotic bacterium although the most common types available are lactic acid bacteria (e.g., Lactobacillus spp.). These bacteria are found normally in the gastrointestinal tract (GIT) of humans and animals and there is the vague notion that the use of indigenous or commensal microorganisms is somehow restoring the natural microflora to the gut. A second class comprises those that are not normally found in the GIT. For example, Saccharomyces boulardii has been shown to be effective in preventing the recurrence of Clostridium difficile-induced pseudo membranous colitis [3] as well as the antagonistic action of Escherichia coli [4]. S. boulardii products are currently being marketed for human use. Within this group of allochthonous probiotic microbes are the sporeforming bacteria, normally members of the genus Bacillus. Here, the product is used in the spore form and thus can be stored indefinitely on the shelf. The use of spore-based products raises a number of questions though. Since the bacterial species being used are not considered resident members of the gastrointestinal microflora how do they exert a beneficial effect? Because the natural life cycle of Initial efforts to document a physiological impact of probiotic bacteria often focus on the following three criteria:
益生菌孢子形成促进宿主健康
益生菌的概念有着悠久的健康声明历史。例如,在波斯语版的《旧约》(创世纪18:8)中,它说“亚伯拉罕的长寿是由于喝了酸牛奶。因此,用非抗生素替代品替代饲料中的抗生素是一种日益增长的必要性。然而,所有生长促进因子的退出并不是一件简单的事情,因为这不仅会影响饲料效率,还会增加动物的死亡率和发病率。孢子形成者只有在植物状态下才有生长和代谢活动的能力,在营养不足或其他生存挑战的情况下才会产生孢子。目前,虽然最常见的益生菌类型是乳酸菌(如乳杆菌),但没有通用的益生菌类别。这些细菌通常存在于人类和动物的胃肠道(GIT)中,并且有一个模糊的概念,即使用本地或共生微生物以某种方式恢复肠道的天然微生物群。第二类包含GIT中通常找不到的类。例如,博拉氏酵母菌已被证明可有效预防艰难梭菌诱导的假性膜性结肠炎[3]的复发,并具有大肠杆菌[4]的拮抗作用。博氏弓形虫产品目前正在上市供人使用。在这组外来益生菌微生物中有孢子形成细菌,通常是芽孢杆菌属的成员。在这里,产品以孢子形式使用,因此可以无限期地储存在货架上。然而,使用基于孢子的产品引发了许多问题。由于所使用的细菌种类不被认为是胃肠道微生物群的常驻成员,它们如何发挥有益的作用?由于益生菌的自然生命周期,最初努力记录益生菌的生理影响通常集中在以下三个标准:
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信